By 2030, 2.7 million people are forecasted to be living with sight loss, costing £6.5bn to the economy. Currently, Ophthalmic staff are struggling with resources in terms of capacity and time, resulting in a delay in treating Cataract, Glaucoma, and AMD. Our solution will help clinicians to identify the conditions earlier so treatment can be planned and blindness can be avoided. Our solution aims to provide quality healthcare in the community, thus improving access to medical care and patient outcomes.
In the UK, it is estimated that nearly 2.1 million people are currently affected by sight loss, of these, around 360,000 are registered as blind or partially sighted. This is predicted to increase to 2.7 million by 2030. Our solution will benefit patients as well as NHS / Wider UK healthcare system.